Simcere Pharmaceutical Group Limited (2096.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 26.76B |
| Enterprise Value | 24.4B |
| P/E Ratio | 16.95 |
| PEG Ratio | 0.23 |
| Price/Sales Ratio | 3.07 |
| Price/Book Ratio | 2.8 |
| Enterprise/Revenue | 2.85 |
| Enterprise/EBITDA | 13.39 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.18 |
| Operating Margin | 0.21 |
AD
Management Effectiveness
| Return On Assets | 0.1 |
| Return On Equity | 0.17 |
Income Statement
| Revenue | 7.73B |
| Revenue/Share | 3.4 |
| Gross Profit | 6.31B |
| EBITDA | 1.72B |
| Net Income | 1.34B |
| Diluted EPS | 0.54 |
Balance Sheet
| Total Cash | 4.06B |
| Total Cash/Share | 1.59 |
| Total Debt | 1.21B |
| Total Debt/Equity | 0.13 |
| Current Ratio | 1.9 |
| Book Value Per Share | 3.72 |
Price History
| 52-Week Change | -18.38 |
| 52-Week High | 15.08 |
| 52-Week Low | 9.07 |
| Moving Average 50 Days | 11.61 |
| Moving Average 200 Days | 12.09 |
Statistics
| Average Volume | 7.24M |
| Shares Outstanding | 2.57B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.18 |
| Trailing Annual Dividend Yield | 1.71 |
| Payout Ratio | 0.25 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
